# Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers

> **NCT00377923** · PHASE1 · COMPLETED · sponsor: **IBSA Institut Biochimique SA** · enrollment: 24 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT00377923
- **Lead sponsor:** IBSA Institut Biochimique SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 24 (—)
- **Last updated:** 2006-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377923, "Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00377923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*